Methazolamide for essential voice tremor.

Author: BusenbarkK, DromeyC, KollerW C, RamigL

Paper Details 
Original Abstract of the Article :
We studied the safety and efficacy of methazolamide (average dose 168 mg/day) in a placebo-controlled blinded investigation in nine patients with essential voice tremor. There were no significant differences for physician or patient clinical rating scores. Digital audio tape recordings showed no dif...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1212/wnl.47.5.1331

データ提供:米国国立医学図書館(NLM)

Methazolamide for Essential Voice Tremor: A Limited Solution

Essential voice tremor can be a challenging condition, causing disruptions in daily life and making communication difficult. This study explored the effectiveness of methazolamide, a medication typically used to treat glaucoma, in treating essential voice tremor. The researchers conducted a placebo-controlled trial involving nine patients and found that while methazolamide did not significantly improve clinical rating scores, it did affect frequency modulation in voice recordings. However, the drug also caused common side effects, suggesting that its usefulness for voice tremor may be limited.

Methazolamide: Limited Efficacy for Voice Tremor

The research suggests that methazolamide may not be a reliable treatment option for essential voice tremor, despite its potential impact on frequency modulation. This highlights the need for continued research into more effective treatments for this condition.

Navigating the Desert of Voice Tremor

For individuals with essential voice tremor, finding an effective treatment can feel like searching for an oasis in a vast desert. This research provides valuable information about the limitations of methazolamide in treating this condition, reminding us that the search for effective solutions continues.

Dr.Camel's Conclusion

This study serves as a reminder that not all potential solutions for health conditions are successful. It highlights the need for continued research and exploration of new treatment approaches to address essential voice tremor and other neurological conditions.

Date :
  1. Date Completed 1996-12-18
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

8909454

DOI: Digital Object Identifier

10.1212/wnl.47.5.1331

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.